The latest release in ACCP’s new Pediatric Self-Assessment Program (PedSAP) focuses on evidence-based updates for the management of pain and sedation in pediatric patients cared being care for in the acute and ambulatory care settings.
Sedation and Analgesia carries a total of 11.5 continuing pharmacy education (CPE) credits. Content was developed under the leadership of Faculty Panel Chair Regine L. Caruthers, Pharm.D.
Chapters in the first module include a general overview of intravenous analgesic and sedative treatment options for hospitalized children and a discussion of oral treatment options for treating pain in the acute and ambulatory care settings. Chapters in the second module review the use of local anesthetics, as well as the role of dexmedetomidine and clonidine in the critically ill patient. The Clinical and Practice Updates module comprises three interactive web-based cases centering on (1) gabapentin in neuropathic pain, (2) opioid tapering, and (3) family education on the use of analgesics in the home.
All PedSAP chapters are fully referenced, with online links to literature compilers such as PubMed. In addition, hypertext links provide ready access to clinical practice guidelines, and other resources. PedSAP releases are designed not only to provide BCPPS recertification credits but also to update the pediatric clinical practitioner and improve patient outcomes.
Publisher: ACCP, 100 pages, September 2017; ISBN-13: 978-1-939862-55-6
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Sedation and Analgesia
I
0217-0000-17-033-H01-P
5.0 CPE Hours
Sedation and Analgesia
II
0217-0000-17-034-H01-P
3.5 CPE Hours
Clinical and Practice Updates I
0217-0000-17-035-H04-P
3.0 CPE Hours